Built for Supply Chain Resiliency and Reliability.
Phlow’s Research & Development Laboratory.

Located in Petersburg, VA
Kilo cGMP Facility.
The Kilo Facility is a small-scale manufacturing facility equipped with two cGMP suites and a 19,200-sq.-ft. dedicated development space for scale-up and continuous flow process refinement to produce APIs. Phlow’s CDMO customers leverage our cutting-edge cGMP kilo and large-scale manufacturing facilities for either batch or continuous processes based in the U.S.

Hybrid Manufacturing Facility.
Our Hybrid Manufacturing Facility is an approximately 18,000-sq.-ft. API manufacturing facility that utilizes continuous advanced manufacturing processes and state-of-the-art automation.

Located in Petersburg, VA

Strategic Active Pharmaceutical Ingredient Reserve.
The Strategic API Reserve (SAPIR™) is built to supply API that can be rapidly converted and accelerate access to critical medicine and medical countermeasure ingredients in the event of a national defense or public health emergency. As part of our unwavering commitment and partnership with the U.S. government, Phlow stands vigilant to global disruption as a result of its network of facilities, including its SAPIR and Strategic Essential Medicine Rapid Availability Platform (SEMRAP™)3 to manage shortages and stabilize the supply chain in times of crisis.

3. SEMRAP™ is currently under development and subject to U.S. Government funding.